Latest Sofinnova Stories
BRISBANE, Calif., July 18, 2011 /PRNewswire/ -- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing.
SUNNYVALE, Calif., June 30, 2011 /PRNewswire/ -- Sorbent Therapeutics, a private biopharmaceutical company developing therapies for cardiovascular and renal disorders, announced today that it has expanded the Company's Series B financing from September 2010 by $36 million.
CAMBRIDGE, England, June 21, 2011 /PRNewswire/ -- Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer.
AMSTERDAM, The Netherlands, June 9, 2011 /PRNewswire/ -- Avantium is proud to announce that it has successfully raised EUR 30 million to advance its breakthrough YXY technology for green building blocks.
MINNEAPOLIS, MN, May 4 /PRNewswire/ - BioAmber Inc., the market leader in biobased succinic acid, has raised $45 million dollars in a Series B financing that will accelerate the commercialization of succinic acid and modified PBS.
- A trick or prank.